CURE

•

Equity

VANECK GENOMICS AND HEALTHCARE INNOVATORS UCITS ETF

TER (bps):

35

AUM (USD m):

6

ISIN:

IE000B9PQW54

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

Global

As of:

24 May 2023

Climate Fund:

No

Benchmark

The MVIS® Global Future Healthcare ESG Index is a global index that tracks the performance of companies that are involved in the genomic health care and electronic healthcare industries. The index is a modified market cap-weighted index with pure-play exposure. MVFHC covers at least 90% of the investable universe.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo

RELATED ARTICLES

Martijn Rozemuller
New Listing

VanEck launches Europe’s first bionic healthcare ETF

The firm has launched two healthcare thematic ETFs within three months

Jamie Gordon

a sign on a rock
New Listing

VanEck launches circular economy ETF

REUS takes the firm’s launch count to 13 so far in 2022

Jamie Gordon

MOST READ

1
Analysis

State Street Global Advisors looks to tokenise ETFs and private assets

Jamie Gordon

2
Analysis

ETFs with the highest exposure to Nvidia

Tom Eckett

3
Analysis

How BlackRock came to dominate ETFs in Europe

Tom Eckett

4
Industry Updates

Vanguard, Invesco and AXA IM join 17 backers of Adamantia consolidated tape bid

Jamie Gordon

5
Industry Updates

Revolut launches ETF trading platform in Europe

Theo Andrew